Literature DB >> 17536804

Transition-state variation in human, bovine, and Plasmodium falciparum adenosine deaminases.

Minkui Luo1, Vipender Singh, Erika A Taylor, Vern L Schramm.   

Abstract

Adenosine deaminases (ADAs) from human, bovine, and Plasmodium falciparum sources were analyzed by kinetic isotope effects (KIEs) and shown to have distinct but related transition states. Human adenosine deaminase (HsADA) is present in most mammalian cells and is involved in B- and T-cell development. The ADA from Plasmodium falciparum (PfADA) is essential in this purine auxotroph, and its inhibition is expected to have therapeutic effects for malaria. Therefore, ADA is of continuing interest for inhibitor design. Stable structural mimics of ADA transition states are powerful inhibitors. Here we report the transition-state structures of PfADA, HsADA, and bovine ADA (BtADA) solved using competitive kinetic isotope effects (KIE) and density functional calculations. Adenines labeled at [6-13C], [6-15N], [6-13C, 6-15N], and [1-15N] were synthesized and enzymatically coupled with [1'-14C] ribose to give isotopically labeled adenosines as ADA substrates for KIE analysis. [6-13C], [6-15N], and [1-15N]adenosines reported intrinsic KIE values of (1.010, 1.011, 1.009), (1.005, 1.005, 1.002), and (1.004, 1.001, 0.995) for PfADA, HsADA, and BtADA, respectively. The differences in intrinsic KIEs reflect structural alterations in the transition states. The [1-15N] KIEs and computational modeling results indicate that PfADA, HsADA, and BtADA adopt early SNAr transition states, where N1 protonation is partial and the bond order to the attacking hydroxyl nucleophile is nearly complete. The key structural variation among PfADA, HsADA, and BtADA transition states lies in the degree of N1 protonation with the decreased bond lengths of 1.92, 1.55, and 1.28 A, respectively. Thus, PfADA has the earliest and BtADA has the most developed transition state. This conclusion is consistent with the 20-36-fold increase of kcat in comparing PfADA with HsADA and BtADA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17536804      PMCID: PMC2522313          DOI: 10.1021/ja072122y

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  42 in total

1.  Refined 2.5 A structure of murine adenosine deaminase at pH 6.0.

Authors:  A J Sharff; D K Wilson; Z Chang; F A Quiocho
Journal:  J Mol Biol       Date:  1992-08-20       Impact factor: 5.469

2.  Purification and partial characterization of brain adenosine deaminase: inhibition by purine compounds and by drugs.

Authors:  J J Centelles; R Franco; J Bozal
Journal:  J Neurosci Res       Date:  1988-02       Impact factor: 4.164

3.  A pre-transition-state mimic of an enzyme: X-ray structure of adenosine deaminase with bound 1-deazaadenosine and zinc-activated water.

Authors:  D K Wilson; F A Quiocho
Journal:  Biochemistry       Date:  1993-02-23       Impact factor: 3.162

4.  Targeting a novel Plasmodium falciparum purine recycling pathway with specific immucillins.

Authors:  Li-Min Ting; Wuxian Shi; Andrzej Lewandowicz; Vipender Singh; Agnes Mwakingwe; Matthew R Birck; Erika A Taylor Ringia; Graham Bench; Dennis C Madrid; Peter C Tyler; Gary B Evans; Richard H Furneaux; Vern L Schramm; Kami Kim
Journal:  J Biol Chem       Date:  2004-12-02       Impact factor: 5.157

5.  Novel, highly potent adenosine deaminase inhibitors containing the pyrazolo[3,4-d]pyrimidine ring system. Synthesis, structure-activity relationships, and molecular modeling studies.

Authors:  Federico Da Settimo; Giampaolo Primofiore; Concettina La Motta; Sabrina Taliani; Francesca Simorini; Anna Maria Marini; Laura Mugnaini; Antonio Lavecchia; Ettore Novellino; Daniela Tuscano; Claudia Martini
Journal:  J Med Chem       Date:  2005-08-11       Impact factor: 7.446

6.  Transition-state structures for N-glycoside hydrolysis of AMP by acid and by AMP nucleosidase in the presence and absence of allosteric activator.

Authors:  F Mentch; D W Parkin; V L Schramm
Journal:  Biochemistry       Date:  1987-02-10       Impact factor: 3.162

7.  Mutational analysis of active site residues of human adenosine deaminase.

Authors:  D Bhaumik; J Medin; K Gathy; M S Coleman
Journal:  J Biol Chem       Date:  1993-03-15       Impact factor: 5.157

8.  Synthesis of nucleotides with specific radiolabels in ribose. Primary 14C and secondary 3H kinetic isotope effects on acid-catalyzed glycosidic bond hydrolysis of AMP, dAMP, and inosine.

Authors:  D W Parkin; H B Leung; V L Schramm
Journal:  J Biol Chem       Date:  1984-08-10       Impact factor: 5.157

Review 9.  Enzymatic transition state poise and transition state analogues.

Authors:  Vern L Schramm
Journal:  Acc Chem Res       Date:  2003-08       Impact factor: 22.384

10.  Transition-state analysis of AMP deaminase.

Authors:  D J Merkler; P C Kline; P Weiss; V L Schramm
Journal:  Biochemistry       Date:  1993-12-07       Impact factor: 3.162

View more
  14 in total

1.  Pyrophosphate interactions at the transition states of Plasmodium falciparum and human orotate phosphoribosyltransferases.

Authors:  Yong Zhang; Vern L Schramm
Journal:  J Am Chem Soc       Date:  2010-06-30       Impact factor: 15.419

2.  Transition-state structure of neisseria meningitides 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase.

Authors:  Vipender Singh; Minkui Luo; Rosemary L Brown; Gillian E Norris; Vern L Schramm
Journal:  J Am Chem Soc       Date:  2007-10-23       Impact factor: 15.419

Review 3.  Binding isotope effects: boon and bane.

Authors:  Vern L Schramm
Journal:  Curr Opin Chem Biol       Date:  2007-09-14       Impact factor: 8.822

Review 4.  Heavy atom labeled nucleotides for measurement of kinetic isotope effects.

Authors:  Benjamin P Weissman; Nan-Sheng Li; Darrin York; Michael Harris; Joseph A Piccirilli
Journal:  Biochim Biophys Acta       Date:  2015-03-27

Review 5.  Purine and pyrimidine pathways as targets in Plasmodium falciparum.

Authors:  María Belén Cassera; Yong Zhang; Keith Z Hazleton; Vern L Schramm
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

6.  Methylthioadenosine deaminase in an alternative quorum sensing pathway in Pseudomonas aeruginosa.

Authors:  Rong Guan; Meng-Chiao Ho; Richard F G Fröhlich; Peter C Tyler; Steven C Almo; Vern L Schramm
Journal:  Biochemistry       Date:  2012-11-02       Impact factor: 3.162

7.  Formulating a fluorogenic assay to evaluate S-adenosyl-L-methionine analogues as protein methyltransferase cofactors.

Authors:  Rui Wang; Glorymar Ibáñez; Kabirul Islam; Weihong Zheng; Gil Blum; Caitlin Sengelaub; Minkui Luo
Journal:  Mol Biosyst       Date:  2011-08-24

Review 8.  Transition States, analogues, and drug development.

Authors:  Vern L Schramm
Journal:  ACS Chem Biol       Date:  2013-01-04       Impact factor: 5.100

9.  Transition states of Plasmodium falciparum and human orotate phosphoribosyltransferases.

Authors:  Yong Zhang; Minkui Luo; Vern L Schramm
Journal:  J Am Chem Soc       Date:  2009-04-08       Impact factor: 15.419

10.  Kinetic isotope effects reveal early transition state of protein lysine methyltransferase SET8.

Authors:  Joshua A Linscott; Kanishk Kapilashrami; Zhen Wang; Chamara Senevirathne; Ian R Bothwell; Gil Blum; Minkui Luo
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.